News

PrEP use in persons with undetected HIV infections contributes to drug resistance and has investigators urging regular screening.

HIV incidence rates in MSM and transgender women taking F/TAF or F/TDF were found to be very low and significantly less than the rate in at-risk individuals not on PrEP in the US.

With 206 cases of measles reported so far in 11 states in 2019, a new study noting that there is no connection between the measles, mumps, rubella (MMR) vaccine and autism has been released.

The rise of Shingrix as a first-choice prophylaxis for shingles has lead to increased demand as the manufacturer commits to ramping up production.

Following FDA approval of a single-tablet bictegravir, emtricitabine, and tenofovir alafenamide regimen for use in adults with HIV, investigators are exploring the safety and efficacy of the same therapy in children and adolescents aged 6 to 18 years.

Weight gain is often a concern for patients on ART. But what about the metabolic impact of PrEP on HIV-uninfected individuals?

DOLPHIN-2 reports that dolutegravir is well-tolerated and achieves more rapid virological suppression prior to delivery compared to efavirenz when initiated during pregnancy.

Bacterial sexually transmitted infections are still prevalent among men who have sex with men in England, but PrEP and other measures have sharply cut the rate of new HIV diagnoses.

A trial comparing raltegravir with efavirenz for antiretroviral therapy in treatment naïve pregnant women with HIV supports the use of raltegravir, especially for women starting ART later in gestation.

Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, has been fighting HIV/AIDS since the 1980s when the virus was first discovered. Now, thanks to a joint effort by multiple arms of the US Department of Health and Human Services, he’s making headway.

Investigators from England report the longest adult HIV remission observed since the Berlin patient.

Over a 12-month study, there was a 13.9% increase of retention with viral load suppression among participants who received rapid viral load results following point-of-care testing.

Vaccine-preventable disease outbreaks are on the rise and social media has a responsibility to help rein it in

Investigators in Denmark showed that a cocktail of common antibiotics could fight resistant E coli and treat urinary tract infections after determining that resistance toward 1 drug leads to sensitivity to another.

Recognizing that many college students are in the riskiest category, agewise, for HIV, new guidelines aim to help providers be more proactive about PrEP.

Influenza vaccines may be less effective in older adults due to a lack of antibody diversity, a new study suggests.

We’ve rounded up a list of important US Food and Drug Administration and US Department of Agriculture recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Although influenza A H1N1 continues to dominate the current flu season in the US, H3N2 viruses are on the rise in some parts of the country.

Violence in the Democratic Republic of Congo has complicated public health efforts and overshadowed strides made in the response to the Ebola outbreak there.

T2 Biosystems, Inc. received FDA Breakthrough Device Designation for its T2Resistane Panel, a new device to aid in the fight against antimicrobial resistance.

Using genome sequencing, investigators have been able to identify clusters of individuals with HIV—with a particular focus on transgender women.

Powassan virus counts in the United States have been on the rise over the last decade, and now a new study sheds light on how ticks rapidly transmit the rare disease.

Women in the South look to family planning providers for more information about HIV PrEP, according a recent study in the journal Contraception.

The Contagion® editorial staff will be providing exclusive written and video coverage from CROI 2019.

State health care-associated infection reporting laws are critical for surveillance, but are they bogging down infection prevention programs?

With 6 ongoing outbreaks, cases reported across 10 states, and the FDA commissioner contemplating federal intervention, measles remains at the forefront of collective consciousness.

UK study in Addiction identifies benefits for controversial programs proposed as a solution for the ongoing opioid crisis.